Cytokine genetics-Polymorphisms, functional variations and disease associations

The Cytokine Handbook

Volumn , Issue , 2003, Pages 19-55

  Gallagher, Grant ^a   Eskdale, Joyce ^a   Bidwell, Jeff L ^b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 10644284300     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012689663-3/50006-5     Document Type: Chapter

References (86)

1. Ahmed S., Ihara K., Sasaki Y., et al. Novel polymorphism in the coding region of the IL-13 receptor alpha' gene: association study with atopic asthma in the Japanese population. Exp. Clin. Immunogenet. 2000, 17:18-22.
2. Al-Janadi M., Al-Dalaan A., Al-Balla S., et al. Interleukin-10 secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B-cell antibody synthesis. J. Clin. Immunol. 1996, 16:145-150.
3. Bidwell J., Keen L., Gallagher G., et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun. 1999, 1:3-19.
4. Bidwell J., Keen L., Gallagher G., et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun. 2001, 2:61-70.
5. Buetler B., Milsark I.W., Cerami A.C. Passive immunisation against cachectin/tumor necrosis factor protects mice from the lethal effects of endotoxin. Science 1985, 229:869-871.
6. Caballero A., Bravo M.J., Nieto A., et al. TNF-A promoter polymorphis and susceptibility to brucellosis. Clin. Expl. Immunol. 2000, 121:480-483.
7. Candore G., Cigna D., Todaro M. T cell activation in HLA-B8, DR3-positive individuals. Early antigen expression defect in vitro. Hum. Immunol. 1995, 42:289-294.
8. Caruso C., Candore G., Modica M.A. Major histocompatibility complex regulation of cytokine production. J. Interferon Cytokine Res. 1996, 16:983-988.
9. Caruso C., Bongiardina C., Candore G. HLA-B8, DR3 haplotype affects lymphocyte blood levels. Immunol. Invest. 1997, 26:333-340.
10. Cox E.D., Hoffmann S.C., DiMercurio B.S., et al. Cytokine polymorphic analyses indicate, ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation 2001, 72:720-726.
11. Dai W.J., Kohler G., Brombascher F. Both innate and acquired immunity to Lysteria monocytogenes infection are increased in IL-10 deficient mice. J. Immunol. 1977, 158:2259-2267.
12. D'Alfonso S., Rampi M., Bocchio D., et al. Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10. Arthritis Rheum. 2000, 43:120-128.
13. de Waal Malefyt R., Yssel H., de Vries J.E. Direct effect of IL-10 on subsets of human CD4+T cell clones and resting T cells: specific inhibition of IL-2 production and proliferation. J. Immunol. 1993, 150:4754-4765.
14. Enk A.H., Angeloni V.T., Udey M.C., Katz S.I. Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. J. Immunol. 1993, 151:2390-2398.
15. Eskdale J., Gallagher G. A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenetics 1995, 42:444-445.
16. Eskdale J., Kube D., Gallagher G. A second polymorphic dinucleotide repeat in the 5' flanking region of the human IL10 gene. Immunogenetics 1996, 45:82-83.
17. Eskdale J., Kube D., Tesch H., Gallagher G. Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics 1997, 46:120-128.
18. Eskdale J., Wordsworth P., Bowman S., et al. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 1997, 49:635-639.
19. Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 1998, 102:1369-1376.
20. Fiorentino D.F., Zlotnic A., Viera P., et al. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 1991, 146:3444-3451.
21. Fleury S., Thibodeau J., Croteau G. HLA-DR polymorphism affects the interaction with DR4. J. Exp. Med. 1995, 182:733-741.
22. Fryer A.A., Spiteri M.A., Bianco A., et al. The -403 GA promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun. 2000, 1:509-514.
23. Gallagher G., Eskdale J., Oh H.H., et al. Polymorphisms in the TNF gene cluster and MHC serotypes in the West of Scotland. Immunogenetics 1997, 45:188-194.
24. Gibson A.W., Edberg J.C., Wu J., et al. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J. Immunol. 2001, 166:3915-3922.
25. Gonzalez E., Dhanda R., Bamshad M., et al. Global survey of genetic variation in CCR5, RANTES, and MIP-1 aplha: impact on the epidemiology of the HIV-1 pandemic. Proc. Natl Acad. Sci. USA 2001, 98:5199-5204.
26. Groux H., Cottrez F., Rouleau M., et al. A transgenic model to analyse the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J. Immunol. 1999, 162:1723-1729.
27. Hagiwara E., Gourley M.F., Lee S., Klinman D.M. Disease severity in systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon-(gamma)-secreting cells in the peripheral blood. Arthritis. Rheum. 1996, 39:370-385.
28. Haukim H., Bidwell J.L., Smith J.L., et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun. 2002, 3(Suppl. 2). (in press).
29. Havell E.A. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J. Immunol. 1989, 143:2894-2899.
30. Houssiau F.A., Lefebvre C., van den Berghe M., et al. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 1995, 4:393-395.
31. Howard T.D., Whittaker P.A., Zaiman A.L., et al. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am. J. Respir. Cell Mol. Biol. 2001, 25:377-384.
32. Hulkkonen J., Pertovaara M., Antonen J., et al. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjogren's syndrome. Arthritis Rheum. 2001, 44:176-179.
33. Ishida H., Hastings R., Kearney J., Howard M. Continuous anti-interleukin-10 antibody administration depletes mice of Ly-1 B-cells but not conventional B-cells. J. Exp. Med. 1992, 175:1213-1220.
34. Ishida H., Muchamunl T., Sakaguchi S., et al. Continuous administration of anti-interleukin-10 antibodies delays the onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 1994, 179:305-310.
35. Jacobs M., Brown N., Allie N., Ryffel B. Fatal Mycobacterium bovis BCG infection in TNF-LT-alpha-deficient mice. Clin. Immunol. 2000, 94:192-199.
36. Kelly J.P., Bancroft G.J. Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes. J. Immunol. 1996, 26:356-364.
37. Kube D., Rieth H., Eskdale J., et al. Structural characterisation of the distal 5' flanking region of the human interleukin-10 gene. Genes Immun. 2001, 2:181-190.
38. Kwiatowski D., Hill A.V.S., Sambou I., et al. TNF concentrations in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 1990, 336:1201-1204.
39. Lazarus M., Hajeer A.H., Turner D., et al. Genetic variation in the Interleukin-10 gene promoter and systemic lupus erythematosus. J. Rheumatol. 1997, 24:2314-2317.
40. Lehmann A.K., Halstenen A., Sornes S., et al. High levels of interleukin-10 in serum are associated with fatality in meningococcal disease. Infect. Immunity. 1995, 63:2109-2115.
41. Levy Y., Brouet J.-C. Interleukin-10 prevents spontaneous cell death of germinal centre B-cells by induction of the Bcl-2 protein. J. Clin. Invest. 1994, 93:424-428.
42. Lio D., Candore G., Cigna D. In vitro T-cell activation in elderly individuals: failure in CD69 and CD71 expression. Mech. Ageing Dev. 1996, 89:51-58.
43. Lio D., Candore G., Romano G.C. Modification of cytokine secretion patterns in subjects bearing the HLA-B8, DR3 phenotype: implications for autoimmunity. Cytokines Cell Mol. Ther. 1997, 3:217-224.
44. Liu X., Nickel R., Beyer K., et al. An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J. Allergy Clin. Immunol. 2000, 106:167-170.
45. Llorente L., Richaud-Patin Y., Wijdenes J., et al. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Newt. 1993, 4:421-430.
46. Llorente L., Richaud-Patin Y., Fior R., et al. In vivo production of Interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus: a potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum. 1994, 37:1647-1655.
47. Llorente L., Zou W., Levy Y., et al. Role of interleukin 10 in the B cell lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 1995, 181:839-844.
48. Llorente L., Richaud-Patin Y., Couderc J., et al. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arth. Rheum. 1997, 40:1429-1435.
49. Majetschak M., Floche S., Obertacke U., et al. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann. Surg. 1999, 230:207-214.
50. Mattey D.L., Hassell A.B., Dawes P.T., et al. Interaction between tumor necrosis factor microsatellite polymorphisms and the HLA-DRB1 shared epitope in rheumatoid arthritis: influence on disease outcome. Arthritis Rheum. 1999, 42:2698-2704.
51. Mehrian R., Quismorio F.P., Strassmann G., et al. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum. 1998, 41:596-602.
52. Mineta M., Tanimura M., Tana T., et al. Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen, in humans. Int. Immunol. 1996, 8:525-531.
53. Mok C.C., Lanchbury J.S., Chan D.W., Lau C.S. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum. 1998, 41:1090-1095.
54. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the Interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
55. Mullighan C.G., Marshall S.E., Bunce M., Welsh K.I. Variation in immunoregulatory genes determines the clinical phenotype of common variable immunodeficiency. Genes Immun. 1999, 1:137-148.
56. Murray P.J., Wang L., Onufry R.C., et al. T-cell derived IL-10 antagonises macrophage function in mycobacterial infection. J. Immunol. 1997, 158:315-321.
57. Negoro K., Kinouchi Y., Hiwatashi N., et al. Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene. Gastroenterology 1999, 117:1062-1068.
58. Nickel R.G., Casolaro V., Wahn U., et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J. Immunol. 2000, 164:1612-1616.
59. O'Garra A., Chang R., Go N., et al. Ly-1 (B-1) B-cells are the main source of B-cell derived interleukin-10. Eur. J. Immunol. 1992, 22:711-717.
60. Padyukov L., Hahn-Zoric M., Lau Y.L., Hanson L.A. Different allelic frequencies of several cytokine genes in Hong-Kong Chinese and Swedish Caucasians. Genes Immun. 2000, 2:280-283.
61. Pantelidis P., Jones M.G., Welsh K.I., et al. Identification of four novel interleukin-13 gene polymorphisms. Genes Immun. 2000, 1:341-345.
62. Pawalec G., Pohla H., Scholtz E., et al. Interleukin-10 is a human T-cell growth factor in vitro. Cytokine 1995, 7:355-363.
63. Paxton W.A., Neumann A.U., Kang S., et al. RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progression. J. Infect Dis. 2001, 183:1678-1681.
64. Petrovsky N., Harrison L.C. Diurnal rhythmicity of human cytokine production-A dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance?. J. Immunol. 1997, 158:5163-5168.
65. Petrovsky N., Harrison L.C. HLA-class 11-associated polymorphism of interferon-gamma production. Implications for HLA disease association. Hum. Immunol. 1997, 53:12-16.
66. Plevy S.E., Targan S.R., Yang H., et al. Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology 1996, 110:1053-1060.
67. Pociot F., Briant L., Jongenee C.V., et al. Association of tumor necrossi factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur. J. Immunol. 1992, 23:224-231.
68. Rood M.J., van Krugten M.V., Zanelli E., et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility in systemic lupus erythematosus. Arthritis Rheum. 2000, 43:129-134.
69. Rousset F., Garcia E., Defrance T., et al. IL-10 is a potent growth and differentiation factor for human B-cells. Proc. Natl Acad. Sci. USA 1992, 89:1890-1893.
70. Sorensen T.T., Nielsen G.G., Andersen P.K., Teasdale T.W. Genetic and environmental influences on premature death in adult adoptees. N. Engl. J. Med. 1988, 318:727-732.
71. Stasi G., Todaro M., De Maria R. Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals. Hum. Immunol. 1997, 55:39-45.
72. Taga K., Mostowski H., Tosado G. Human interleukin-10 can directly inhibit T-cell growth. Blood 1993, 81:2964-2971.
73. Tountas N.A., Cominelli F. Identification and initial characterisation of two polymorphisms in the human interleukin-10 promoter. Eur. Cytokine Netw. 1996, 7:578. (Abstr.).
74. Tumpey T.M., Elner V.M., Chen S.H., et al. Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1. J. Immunol. 1994, 153:2258-2265.
75. Turner D.M., Williams D.M., Sankaran D., et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenetics 1997, 24:1-8.
76. van den Broek M., Bachmann M.F., Kohler G., et al. IL-4 and IL-10 antagonise IL-12 mediated protection against acute Vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2. J. Immunol. 2000, 164:371-378.
77. van der Poll T., Marchant A., Keogh C.V., et al. Interleukin-10 impairs host defence in murine pneumococcal pneumonia. J. Infect. Dis. 1996, 174:994-1000.
78. van der Pouw Kraan T.C., van Veen A., Boeije L.C., et al. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun. 1999, 1:61-65.
79. van Dissel J.T., van Langevelde P., Westendorp R.G., et al. Anti-Inflammatory cytokine profile and mortality in febrile patients. Lancet 1998, 351:950-953.
80. Vassalli P. The pathophysiology of tumor necrosis factor. Annu. Rev. Immunol. 1992, 10:411-452.
81. Wagner R.D., Maroushek N.M., Brown J.F., Czuprynski C.J. Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice. Infect. Immun. 1994, 62:2345-2353.
82. Wanidworanun C., Strober W. Predominant role of tumour necrosis factor-alpha in human monocyte IL-10 synthesis. J. Immunol. 1993, 151:6853-6861.
83. Weissensteiner T., lanchbury J.S. TNFB polymorphisms characterize three lineages of TNF region microsatellite haplotypes. Immunogenetics 1997, 47:6-16.
84. Westendorp R.G.J., Langermans J.A.M., Huizinga T.W.J., et al. Genetic influence on cytokine production in fatal meningococcal disease. Lancet 1997, 349:170-173.
85. Westendorp R.G., Langermans J.A., Huizinga T.W., et al. Genetic influence on cytokine production in meningococcal disease. Lancet 1997, 349:1912-1913.
86. Wilson A.G., di Giovine F.S., Duff G.W. Genetics of tumour-necrosis factor-a in autoimmune, infectious and neoplastic disease. J. Inflamm. 1995, 45:1-12.